XML 52 R38.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

12 Months Ended

Oct. 31, 2021

Share-based Payment Arrangement [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable as of October 31, 2021, is:


	Shares (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Stock Options Outstanding at October 25, 2020	21,073	$	30.39
Granted	1,277	47.45
Exercised	(3,050)	17.61
Forfeited	(277)	37.23
Expired	(1)	36.25
Stock Options Outstanding at October 31, 2021	19,022	$	33.49	4.9	$	182,432
Stock Options Exercisable at October 31, 2021	13,047	$	29.91	3.8	$	164,766

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised during each of the past three fiscal years, are:


	Fiscal Year Ended
	October 31,		October 25,		October 27,
(in thousands, except per share amounts)	2021		2020		2019
Weighted-average Grant Date Fair Value	$	7.52	$	7.71	$	9.24
Intrinsic Value of Exercised Options	94,108		182,821		138,282

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:


	Fiscal Year Ended
	October 31,		October 25,		October 27,
	2021		2020		2019
Risk-free Interest Rate	1.0	%	1.7	%	2.8	%
Dividend Yield	2.1	%	2.0	%	1.9	%
Stock Price Volatility	20.0	%	19.0	%	19.0	%
Expected Option Life	7.4 years		7.5 years		8.0 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted stock units as of October 31, 2021, is:


	Shares (in thousands)	Weighted- Average Grant Date Fair Value		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Restricted Stock Units Outstanding at October 25, 2020	188	$	45.91
Granted	225	47.52
Dividend Equivalents	6	46.62
Vested	(31)	46.56
Forfeited	(3)	46.52
Restricted Stock Units Outstanding at October 31, 2021	385	$	46.81	1.7	$	16,277

A reconciliation of the restricted shares as of October 31, 2021, is:


(in thousands, except per share amounts)	Shares	Weighted- Average Grant Date Fair Value
Restricted Shares Outstanding at October 25, 2020	45	$	47.03
Granted	38	46.92
Vested	(45)	47.03

Restricted Shares Outstanding at October 31, 2021	38	$	46.92

Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted

The weighted-average grant date fair value of restricted stock units granted and the total fair value of restricted stock units granted during each of the past three fiscal years, are:


	Fiscal Year Ended
	October 31,		October 25,		October 27,
(in thousands, except per share amounts)	2021		2020		2019
Weighted-average Grant Date Fair Value	$	47.52	$	45.88	$	—
Fair Value of Restricted Stock Units Granted	10,699		9,383		—
Fair Value of Restricted Stock Units Vested	$	1,460	$	839	$	—

The weighted-average grant date fair value of restricted shares granted, the total fair value of restricted shares granted, and the fair value of shares that have vested during each of the past three fiscal years are:


	Fiscal Year Ended
	October 31,		October 25,		October 27,
(in thousands, except per share amounts)	2021		2020		2019
Weighted-average Grant Date Fair Value	$	46.92	$	47.29	$	42.23
Fair Value of Restricted Shares Granted	1,760		1,973		2,134
Fair Value of Restricted Shares Vested	$	2,133	$	1,974	$	1,760